Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users
Genes · 10.02.2023 · 14 (2) · 456
DOI: 10.3390/genes14020456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 10.02.2023. Verfasst von Marleen E Jansen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Amsterdam Public Health Research Institute, Personalized Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Sect…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Public Health and the Environment (RIVM).
Abstract (Originalsprache)
Pharmacogenomic testing is a method to prevent adverse drug reactions. Pharmacogenomics could be relevant to optimize statin treatment, by identifying patients at high risk for adverse drug reactions. We aim to investigate the clinical validity and utility of pre-emptive pharmacogenomics screening in primary care, with SLCO1B1 c.521T>C as a risk factor for statin-induced adverse drug reactions. The focus was on changes in therapy as a proxy for adverse drug reactions observed in statin-users in a population-based Dutch cohort. In total, 1136 statin users were retrospectively genotyped for the SLCO1B1 c.521T>C polymorphism (rs4149056) and information on their statin dispensing was evaluated as cross-sectional research. Approximately half of the included participants discontinued or switched their statin treatment within three years. In our analyses, we could not confirm an association between the SLCO1B1 c.521T>C genotype and any change in statin therapy or arriving at a stable dose sooner in primary care. To be able to evaluate the predictive values of SLCO1B1 c.521T>C genotype on adverse drug reactions from statins, prospective data collection of actual adverse drug reactions and reasons to change statin treatment should be facilitated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics, Amsterdam Public Health Research Institute, Personalized Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Section Community Genetics, 1081 HV Amsterdam, The Netherlands.
- Centre for Health Protection, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.
- Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, The Netherlands.
- Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.
- Department of Pulmonary Medicine and Amsterdam Public Health Research Institute, Personalized Medicine, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
ORCID-Profile: Marleen E Jansen, Tessel Rigter, Patrick C Souverein, Jesse J Swen, Martina C Cornel
Förderung
- National Institute for Public Health and the Environment (RIVM)
Zitieren
APA
Jansen, M. E., Rigter, T., Fleur, T. M. C., Souverein, P. C., Verschuren, W. M. M., Vijverberg, S. J., Swen, J. J., Rodenburg, W., & Cornel, M. C. (2023). Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users. Genes, 14(2), 456. https://doi.org/10.3390/genes14020456
Vancouver
Jansen ME, Rigter T, Fleur TMC, Souverein PC, Verschuren WMM, Vijverberg SJ, et al. Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users. Genes. 2023;14(2):456. doi:10.3390/genes14020456
BibTeX
@article{Jansen2023,
author = {Jansen, Marleen E and Rigter, Tessel and Fleur, Thom M C and Souverein, Patrick C and Verschuren, W M Monique and Vijverberg, Susanne J and Swen, Jesse J and Rodenburg, Wendy and Cornel, Martina C},
title = {Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users},
journal = {Genes},
year = {2023},
volume = {14},
number = {2},
pages = {456},
doi = {10.3390/genes14020456}
}
EUVIMED